An official website of the United States government Here's how you know

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 206441
Company: PADAGIS ISRAEL

Products on ANDA 206441

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
DESOXIMETASONE	DESOXIMETASONE	0.25%	SPRAY;TOPICAL	Prescription	AT	No	No

Approval Date(s) and History, Letters, Labels, Reviews for ANDA 206441

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
01/20/2017	ORIG-1	Approval		STANDARD		Label is not available on this site.

Supplements

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
08/23/2023	SUPPL-3	Labeling-Package Insert		Label is not available on this site.

Therapeutic Equivalents for ANDA 206441

DESOXIMETASONE

SPRAY;TOPICAL; 0.25%
TE Code = AT

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
DESOXIMETASONE	DESOXIMETASONE	0.25%	SPRAY;TOPICAL	Prescription	No	AT	208124	LUPIN
DESOXIMETASONE	DESOXIMETASONE	0.25%	SPRAY;TOPICAL	Prescription	No	AT	206441	PADAGIS ISRAEL
TOPICORT	DESOXIMETASONE	0.25%	SPRAY;TOPICAL	Prescription	Yes	AT	204141	SUN PHARMA CANADA

Top